Formulation

Aug 25, 2017
By BioPharm International Editors
The generic pharmaceuticals firm has sold its Baddi, India formulations manufacturing facility following a recent fire at its joint-venture plant in Algeria.
Aug 16, 2017
By BioPharm International Editors
The US Patent and Trademark Office issued three new patents that extend protection for Alexion’s rare-disease drug, Soliris, for an additional 10 years.
Aug 07, 2017
By BioPharm International Editors
Lonza further expands its micronization services with the acquisition of Swiss contract manufacturer, Micro-Macinazione, following its previous $5.5-billion acquisition of dosage form provider, Capsugel.
Aug 01, 2017
BioPharm International
Managing and prioritizing risk is essential to ensuring raw material quality. USP is developing new guidelines to make the work easier.
Aug 01, 2017
BioPharm International
Media manufacturers are focused on reducing risk, improving quality and consistency, and managing costs.
Jul 21, 2017
By BioPharm International Editors
Catalent Applied Drug Delivery Institute announced a partnership with Rutgers University to examine the challenges of pediatric drug formulation and delivery.
Jun 07, 2017
By BioPharm International Editors
The United Kingdom’s Center for Process Innovation (CPI) is investing in a new project, Microstar, which seeks to reduce risk for formulators through the development of accelerated screening methods for predictive design.
May 31, 2017
By BioPharm International Editors
Microdermics will focus on product development and clinical activities of new drug delivery methods, while Vetter’s primary role will be in the fill and finish aspect.
May 01, 2017
BioPharm International
The unique structures of fusion proteins lead to expression, heterogeneity, and stability issues.
Apr 01, 2017
BioPharm International
Including next-gen antibodies in pharma pipelines is considered essential for future success.
native1_300x100
lorem ipsum